Patent · US Active

Biosynthesis of eriodictyol from engineered microbes

US10975403B2 · kind B2 · utility

0Cited by
3References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2018
Grant dateApr 13, 2021
Priority date
Expiry dateJul 11, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y105/0103
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the production of eriodictyol via bioconversion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.